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Abstract
Legionella pneumophila genotyping is important for epidemiological investigation of nosoco-
mial and community-acquired outbreaks of legionellosis. The prevalence of legionellosis in
pneumonia patients in the West Bank was monitored for the first time, and the sequence
types (STs) from respiratory samples were compared with STs of environmental samples
from different wards of the hospital. Sputum (n = 121) and bronchoalveolar lavage (BAL)
(n = 74) specimens were cultured for L. pneumophila; genomic DNA was tested by 16S
rRNA polymerase chain reaction (PCR) amplification. Nested PCR sequence-based typing
(NPSBT) was implemented on DNA of the respiratory and environmental PCR-positive sam-
ples. Only one respiratory specimen was positive for L. pneumophila by culture. BAL gave a
higher percentage of L. pneumophila-positive samples, 35% (26/74) than sputum, 15% (18/
121) by PCR. NPSBT revealed the following STs: ST 1 (29%, 7/24), ST 461 (21%, 5/24), ST
1037 (4%, 1/24) from respiratory samples, STs from environmental samples: ST 1 (28.5%,
4/14), ST 187 (21.4%, 3/14) and ST 2070, ST 461, ST 1482 (7.1%, 1/14) each. This study
emphasises the advantage of PCR over culture for the detection of L. pneumophila in countries
where antibiotics are indiscriminately used prior to hospital admission. ST 1 was the predom-
inant ST in both respiratory and environmental samples.
Introduction
Legionella infections are an important cause of community- and hospital-acquired pneumo-
nia, known as Legionnaires’ disease (LD). In addition, Legionella can cause water-based out-
breaks of public health implications [1]. Legionella infections or legionellosis varies in severity
from a mild febrile illness known as pontaic fever to a serious and sometimes fatal form of
atypical pneumonia called LD [2]. Legionellosis is a notifiable disease in all European
Union countries [3], while in developing countries it is under-reported; this is mainly due
to underdiagnosis by clinicians who only rarely test for LD before implementing antibiotic
therapy that is likely to cover Legionella spp [4].
In the West Bank, Palestine, LD is not a notifiable disease, and prior to this study, no infor-
mation about the prevalence of Legionella spp. in environmental and clinical samples was
available. Legionella pneumophila is the aetiological agent of approximately 90% of legionello-
sis cases [5], and L. pneumophila serogroup 1 (sg 1) is the predominant cause [6]. Isolation of
L. pneumophila by culture is considered the ‘gold standard’ for the diagnosis of LD [2], but
culture-confirmed diagnosis of Legionella infections is often hampered by the demanding cul-
ture requirements that need professional personnel and by early antibiotic treatment [7, 8].
According to the WHO Essential Medicines and Health Products report, there is irrational
use of drugs in Palestinian National Authority (PNA) health institutions, and most patients
use antibiotics prior to hospital admission [9, 10], making it difficult to isolate L. pneumophila
strains from clinical specimens. On the other hand, molecular diagnostic techniques for L.
pneumophila from respiratory samples, such as polymerase chain reaction (PCR), are well
established and increasingly adopted worldwide [2, 11]. Endpoint and real-time PCR offer
substantial advantages over cultivation for the detection and quantification of L. pneumophila,
including high sensitivity, specificity and time efficiency [12–15]. For epidemiological studies,
in addition to detection and diagnosis, several rapid and discriminatory methods have been
developed for Legionella typing; DNA banding pattern-based and DNA sequencing-based
genotyping (among others, Ref) are widely used methods for subtyping of bacteria.
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Pulsed-field gel electrophoresis, an example of DNA banding
method, is based on enzymatic restriction, but it requires high-
quality DNA, which is poorly applicable to human or environ-
mental samples, and may lack the resolution power to distinguish
bands of nearly identical size.
Restriction fragment length polymorphism (RFLP) patterns
are mainly determined through the specific combination of
restriction enzymes and nucleic acid probes (Southern blotting).
RFLP analysis requires large amounts of high-quality genomic
DNA, which can limit its application in many cases. In addition,
it is time and labour consuming, especially when coupled with
Southern blotting, and involves detection systems that use either
radioisotopes or complex biochemistry.
On the other hand, multiple-locus variable number tandem
repeat analysis (MLVA) based on the number of tandem repeats
per locus that may vary dramatically between strains within a
given species. MLVA is a PCR-based genotyping method based
on the polymorphic analysis of multiple variable number tandem
repeat loci on the chromosome; it is a rapid, easy to perform,
inexpensive and reproducible genotyping method with high reso-
lution. Nevertheless, by comparison of genotyping methods,
sequence-based typing (SBT) is considered more rapid and easier
to perform and provides unambiguous results, and hence is con-
sidered the current gold standard for high-resolution genotying of
L. pneumophila [16–19]. SBT is based on the comparison of gene
sequences from seven loci ( flaA, pilE, asd, mip, mompS, proA and
neuA) [16, 17]. Another commonly used test for diagnosis of LD
is the urinary antigen (UAG) [6]. UAG is known for its high sen-
sitivity (96%) and specificity (99.9%). However, the UAG test
detects only L. pneumophila serogroup 1 (Lp1) while non-Lp1
LD is missed [20] and its diagnostic window is <2 weeks after
infection. Still, because of its high cost, the UAG test is unlikely
to be widely used in economically underdeveloped regions like
the West Bank.
In the present study, our aim was to assess the prevalence of
L. pneumophila in respiratory secretions from suspected pneumo-
nia patients in the West Bank, by implementing molecular methods
for the detection of L. pneumophila, and to determine the genotype
of the PCR-positive samples in situ, by nested PCR sequence-based
typing (NPSBT). For this purpose, we performed a 2-year prospect-
ive survey to detect L. pneumophila in respiratory tract secretions
from patients with suspected pneumonia from a central hospital
in the West Bank. Nested SBT was used for genotyping of the
PCR-positive specimens. The need for such a study was eminent
to evaluate nosocomial threats of L. pneumophila, especially that
our previous work in the same laboratory showed the abundant
prevalence of L. pneumophila in water systems in eight hospitals
in the West Bank, Palestine (unpublished data)
Methodology
Study site and inclusion criteria
The clinical samples were collected from suspected pneumonia
patients admitted to a hospital in East Jerusalem in the period
between September 2014 and June 2016, after signing a written
informed consent form and ethical approval from Al-Quds
University and the Hospital’s Ethical Committee.
Sampling of clinical and environmental material
Bronchoalveolar lavage (BAL) samples (n = 74) and sputum sam-
ples (n = 121) were collected from suspected pneumonia patients
by the pulmonologist; sterile containers with screw caps were sent
to Bacteriology laboratory of the Hospital. The samples were
stored at 4 °C until received by the Microbiology Research
Laboratory at Al-Quds University within 24 h.
Drinking water was collected from the main water source of
each site and several biofilm swabs from faucets, showerheads
and hoses. A total of 5 litres of each water sample was collected
and filtered onto sandwich membrane filters composed of
nucleopore-filter (Nuclepore Track-Etch Membrane, MB 90 mm,
0.2 µm, Whatman, England) and glass fibre-microfilter (GF/F)
(GFF, 90 mm,Whatman, England). Swabs from the respective sur-
faces were obtained for DNA extraction using sterile cotton swabs
(Cotton Tipped Applicator, China). Both types of environmental
samples were store frozen (−20 °C) for later analysis.
Culture of sputum and BAL samples
BAL and sputum samples (sputum samples were treated ther-
mally (56 °C for 10 min)) and then inoculated onto GVPC
(Glycine–Vancomycin–Polymyxin Cycloheximide; Heidelberg,
Germany) Legionella-selective agar medium. Plates were incu-
bated at 37 °C for 7 days. Five colonies of each positive sample
were selected and re-isolated on GVPC plates. Identification of
Legionella spp. was confirmed by the ability to grow on GVPC
and inability to grow on blood agar (M073, HI media, India)
(L-cysteine free) plates. Positive samples were re-streaked on
BCYE and further identified by an agglutination test using
Legionella Latex Test (Oxoid DR0800M, England) according to
manufacturer’s instruction. The test allows a separate identifica-
tion of L. pneumophila serogroup 1 (sg 1) and serogroups 2–14.
DNA extraction from clinical and environmental material
The BAL or sputum samples were stored at 4 °C until processed
within 24–48 h; samples were vortexed for 10 s and 1–2 ml of
each sample was transferred to a fresh sterile tube. Genomic
DNA was extracted from each BAL and sputum sample by
using DNA extraction kit (Qiagen, 69506, Germany). Briefly,
2 ml of BAL and 1 ml of sputum was centrifuged at 17 000g for
10 min then the pellet was suspended in 250 µl of sputum lysis
buffer (20 mM Tris-HCl, 2 mM EDTA, 1.2% Triton X-100
(9002-93-1, Sigma-Aldrich, Germany) [pH 8.0]) containing
10 mg/ml lysozyme (62970, Fluka, Sigma-Aldrich, Switzerland)
with 250 µl of molecular grade water (Promega, USA), then incu-
bated at 37 °C for 30 min (with shaking at 1500 rpm). The sam-
ples were centrifuged at 17 000g for 15 min, and then the
supernatant was discarded. Eighteen microlitres of ATL buffer
was added with 20 µl of proteinase K (15 mg/ml) and incubated
at 56 °C for 1 h (with shaking at 1500 rpm), then 200 µl of AL
buffer was added to the sample and incubated at 70 °C for
10 min, then 200 µl of ethanol (96–100%) was added and mixed
by vortexing, the samples were loaded onto the spin column
and centrifuged at 17 000g for 1 min, then 500 µl of AW1 buffer
was added and centrifuged at 6000g for 1 min, then 500 µl of
AW2 buffer was added, then centrifuged at 17 000g for 3 min,
then the spin column was placed in a new 2 ml collection tube
and 100 µl of AE buffer or distilled water was added then centri-
fuged at 6000g. Extracted DNA was stored at −20 °C.
Biofilm swabs from anterior surfaces of faucets, showerheads
or shower hoses from wards of patients positive for L. pneumo-
phila were incubated with 220 µl lysis buffer (2x TE) containing
10 mg/ml lysozyme (Sigma) and 15 mg/ml proteinase K (Qiagen)
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for 20 min at 37 °C. Three hundred and fifty microlitres of
AL-buffer (DNeasy kit, Qiagen) were added to two replicate
swabs followed by incubation for 5 min at 70 °C. The lysate was
removed from the swab by a short spin down and absolute ethanol
was added to the lysate (ratio lysate/ethanol 2:1). The mixture was
applied to the spin-column of the kit, then the manufacturer’s
instructions were followed. Nucleic acids were eluted from the
columns with DNase/RNase-free water and stored at −20 °C.
More details on the sampling and DNA extraction of water and
biofilm samples are provided by Henne et al. [21].
Screening of BAL and sputum samples for L. pneumophila
by PCR
Endpoint PCR assays targeting the 16S rRNA gene were used for
identification of L. pneumophila in BAL and sputum samples.
Primers for L. pneumophila species, L1F 5′-CCTGGGCTAA
CCTGGGAC-3′ and L1R 5′-CTTAGACTCCCCACCATCACA
T-3′, were purchased from Hylabs (Rehovot, Israel). AccuPower®
HotStart PCR PreMix was used for PCR amplification; to each
AccuPower® HotStart PCR PreMix tube, a mixture of 0.8 µl
(10 mmol) forward primer (L1F), 0.8 µl (10 mmol) reverse pri-
mer (L1R) and 4 µl (100 ng/μl) DNA template was distributed
into each PreMix, and 14.4 µl molecular grade water (Promega)
was added. PCR amplification was done using a thermal cycler
(model 1861096, Biorad, USA) at the following conditions:
denaturation at 94 °C for 5 min followed by 35 cycles of denatur-
ation at 94 °C for 45 s, annealing at 55 °C for 60 s, elongation at
72 °C for 45 s and final elongation at 72 °C for 5 min. PCR
products were analysed by agarose gel electrophoresis to check
for the correct amplicon size (544 bp). DNA of Legionella re-
ference strain L. pneumophila subsp. pneumophila Philadelphia
1 ATCC33152 was used as positive DNA control throughout
the study. Molecular grade water (Promega) was used as negative
control in all PCR assays.
Molecular typing by NPSBT
NPSBT was used to obtain typing data for L. pneumophila from
BAL and sputum samples as well as from environmental samples
(biofilm) collected from different wards of the same hospital.
The starting material used for genotyping was DNA of samples
which were confirmed to be positive for the presence of
L. pneumophila by PCR. The procedure of the European
Working Group for Legionella Infections (EWGLI), Nested-SBT
(version 2.0) was applied as detailed at http://www.hpa-bioinfor-
matics.org.uk/legionella/legionella_sbt/php/sbt_homepage.php.
In brief, the protocol included two rounds of PCR: the first
round of PCR was carried out with seven primer pairs ( flaA,
pilE, asd, mip, mompS, proA, neuA) [22], which bind externally
to those used in the second-round PCR for another seven primer
pairs. PCR products of the first round was the starting material
for the second-round PCR; the PCR products from the second
round were sent to Hylabs, Israel, for purification and sequencing;
the second-round primers were used as sequencing primers.
Sequencing results were submitted to the online Legionella SBT
Quality Tool www.hpa-bioinformatics.org.uk/cgibin/legionella/
sbt/seq_assemble_legionella1.cgi which was used to assign indi-
vidual allele numbers based on comparison of the sequences to
STs of L. pneumophila in the database. For each isolate, the com-
bination of seven alleles was defined as a seven-digit allelic profile
by using the predetermined order flaA, pilE, asd, mip, mompS,
proA and neuA (e.g. 1-4-3-1-1-1-1) and a ST represented by a
number (e.g. ST 1); if less than seven-allele profile was obtained
(5–6), it was usually sufficient to identify the strain as belonging
to one or two STs, three- or four-allele profiles sufficient to
differentiate one profile from another.
Results
Clinical data
The study included 195 respiratory specimens including 74 BAL
and 121 sputum samples collected from suspected pneumonia
patients that were hospitalised at a hospital in East Jerusalem,
in the period between September 2014 and June 2016. Patients
that had showed more than one positive result were counted as
one considering the department of the first positive sample.
The age of the patients ranged between 3 months and 86 years.
Patients were hospitalised in the following departments: internal
medicine, intensive care unit (ICU), paediatric, paediatric ICU,
surgery and gynaecology (Fig. 1).
Detection of L. pneumophila in respiratory samples by
cultivation
All respiratory samples (74 BAL and 121 sputum samples) were
tested by cultivation-dependent analysis by plating on GVPC-
selective media. Only one of the total 195 samples was positive
for L. pneumophila by routine bacteriological culture method.
This very low yield may be explained due to the regimen of
antibiotics heavily used by patients prior to hospitalisation.
Prevalence of L. pneumophila in respiratory samples
determined by PCR
PCR analysis of 195 respiratory samples for L. pneumophila
revealed 23% positive and 77% negative samples in all analyses.
This molecular detection of L. pneumophila in the sputum sam-
ples (n = 121) resulted in 18 (15%) positive and 103 (85%) nega-
tive samples, whereas analysis of the BAL samples (n = 74)
showed 26 (35%) positive and 48 (65%) negative samples (Fig. 2).
Comparison of allele profiles from respiratory and
environmental samples
Out of 44 samples positive for L. pneumophila by PCR, 34 respira-
tory samples were selected and processed for NPSBT method
Fig. 1. Distribution of Legionella pneumophila – positive samples (n = 44) by PCR,
from pneumonia patients according to hospital departments.
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according to the EWGLI standard scheme as explained in
materials and methods. Gel electrophoresis of amplicons for
the nested PCR of the 34 selected respiratory samples showed
that 24 positive samples displayed at least four out of
seven-allele products. The relevant bands of these 24 samples
were sequenced. In addition, 15 environmental positives for
L. pneumphila samples obtained from the different wards of
the hospital were typed by NPSBT. The aim is to compare the
STs obtained for the respiratory samples, with the STs of
the environmental samples to find any nosocomial link. Of
these environmental samples, 14 samples (positive for six- or
seven-allele products) were sent to sequencing; one sample
was only positive for one allele and excluded from further
analysis.
The sequencing files were submitted to the respective website
for quality check and identification of the corresponding STs.
The following STs for respiratory samples were identified: ST
1 (29%, 7/24), ST 461 (21%, 5/24), ST 1037 (4%, 1/24) and
46% (11/24) undetermined profile (Fig. 3a). ST 1 was the most
predominant ST in the respiratory samples. The results of STs
of environmental samples revealed five different STs: ST 1
(28.5%, 4/14), ST 187 (21.4%, 3/14), one sample of ST 2070,
ST 461 and ST 1482 (7.1%, 1/14), while the rest of the sam-
ples (28.5%, 4/14) was of unspecified STs (Fig. 3b). The most
prevalent ST in the environmental samples was, like in the clinical
samples, ST 1.
Discussion
Worldwide there has been a rising awareness regarding LD since
it was first detected after an outbreak in 1976 in Philadelphia,
USA. According to the recent European Center of Disease
Prevention and Control (ECDC) report, 7022 cases were reported
by 29 countries in the European Union during 2015 of which
approximately 8% were fatal [3]. However, in the West Bank,
Palestine, LD is not a notifiable disease, and prior to this study,
there was no previous record about the prevalence of Legionella
spp. in environmental or respiratory samples. In a parallel
study, we addressed the prevalence of Legionella spp. in drinking-
water supply systems (DWSS) in eight major hospitals in the West
Bank for a period of 3 years (2012–2015) and observed that all
DWSS were contaminated with Legionella spp. (manuscript in
preparation). Cultivation as well as molecular methods were
applied in the current study and revealed a prevalence for
Legionella spp. of 8.3% for water samples by culture, this percent-
age increased to 50% using PCR-based detection. As for biofilms,
the Legionella prevalence was more evident, being 16.8% by
culture vs. 61% by PCR analysis (data not shown).
Sputum samples collected from suspected pneumonia patients
that were hospitalised at a hospital in East Jerusalem, in the period
between September 2014 and June 2016. The age of the patients
ranged between 3 months and 86 years. Patients were hospitalised
in the following departments: internal medicine, ICU, paediatric,
Fig. 2. (a) Prevalence of Legionella pneumophila in the
respiratory samples (n = 121) collected from a hospital
in Jerusalem as determined by PCR in DNA from BAL
and sputum samples. (b) Prevalence of L. pneumophila
from environmental samples of West Bank (eight sites)
and a hospital in Jerusalem.
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surgery paediatric ICU and gynaecology (Fig. 1). Paediatric
patients showed a relatively high percentage of positive results
which stresses further investigation or use of more advanced typ-
ing methods, like whole-genome sequencing (WGS) to decide
whether the source of infection was nosocomial, or community-
acquired. More surveillance steps should be taken.
Respiratory tract samples, including sputum and BAL samples,
(n = 195) were collected from suspected pneumonia patients
admitted to a hospital in East Jerusalem in the period between
September 2014 and September 2015. This hospital is the only
centre that can perform bronchoscopy to obtain BAL in the
West Bank. Patients from all over the West Bank suspected of
pulmonary infections needing bronchoscopy had their BAL sam-
ples extracted and examined in this medical centre. Therefore, we
considered this centre to be representative for the whole of
the population of the West Bank. The clinical samples (sputum
n = 121, BAL n = 74) were cultured on agar medium selective
for Legionella before DNA extraction. Only one sample was posi-
tive by the culture method [23, 24]. This very low yield of
Legionella isolates from respiratory samples may be attributed to
antibiotics being used prior to hospital admission.
In complementation to cultivation, we adopted molecular
diagnostic approaches for Legionella infections which are imple-
mented worldwide due to their high sensitivity, specificity and
time efficiency [2]. Conventional PCR targeting the 16S rRNA
gene was applied using DNA extracted directly from sputum
and BAL samples collected from suspected pneumonia patients.
Our results showed that 44 out of 195 samples (23%) of re-
spiratory tract samples were positive for L. pneumophila, by con-
ventional PCR. This indicates an annual incidence rate of 0.76 in
1 00 000 individuals, which coincides with many European coun-
tries, where LD has an overall incidence of 1.16 per 1 00 000 indi-
viduals of the EU. In Israel, a crude incidence of 0.67 cases/1 00
000 was reported in 2013 [25].
In our study, BAL samples appeared to be sensitive and
showed a higher percentage of positive PCR results (35%),
whereas sputum samples showed lower per cent of positivity
(15%) (Fig. 2a). Environmental samples (water and biofilms) in
eight different hospitals in the West Bank besides Jerusalem
were also abundant with Legionella spp. PCR detected a higher
per cent of positive samples than culture-based detection
(Fig. 2b). In addition to Legionella detection in clinical material,
typing of Legionella strains is of considerable importance in deter-
mining sources of nosocomial legionellosis [26]; therefore, we
adopted NPSBT as a highly discriminatory typing method to pro-
vide useful information about the sources of infection particularly
because it could be applied in situ where no Legionella isolates
could be obtained.
In our study, we applied NPSBT to a set of clinical and pre-
sumptively linked environmental samples, i.e. the different hos-
pital wards where the PCR-confirmed L. pneumophila patients
were admitted in quest of any nosocomial link. Thirty-four
PCR-positive respiratory specimens were tested by NPSBT using
the protocol described previously [27]. After submission of the
data files to the respective website, complete profiles (seven-allele)
from the DNA of respiratory tract samples were obtained for 8.8%
of the specimens, a further 53% resulted in five- or six-allele pro-
file usually sufficient to identify the strain as belonging to one or
two STs. A total of 17.6% of the samples gave three- or four-allele
profile, which was sufficient to differentiate one profile from
another without determining their ST precisely. Finally, 20.5%
of the samples gave one- or two-allele profile for which we
could not determine an ST. The STs and their distribution were
as follows: ST 1 (32%), ST 461 (23%), ST 1037 (4%) and 46%
undetermined allele profiles (Fig. 3a). ST 1 was the most predom-
inant ST in the clinical samples. The results of the NPSBT analysis
for the environmental samples (biofilm) revealed five different
STs and their abundances as follows: ST 1 (28.5%), ST 187
(21.4%), one sample of each of ST 2070, ST 461 and ST 1482
(7.1%), while four samples contained unspecific STs. The most
predominant ST in the selected environmental samples was also
ST 1; this result is in agreement with our previous study which
included eight hospitals in the West Bank; using MLVA for the
genotyping of L. pneumophila isolates, the most prevalent geno-
type for our hospital as well as the other hospitals included in
the survey was MLVA-genotype 4 which corresponds to ST 1
(Zayed et al., manuscript in preparation). On a global basis, ST
1 is the most predominant ST of L. pneumophila, [28] being
more virulent than other STs [29].
This study demonstrates the advantage of PCR-based ap-
proaches for sensitive detection and high-resolution identification
of L. pneumophila in clinical samples, particularly, in a country
where most patients use antibiotics prior to hospital admission;
unfortunately, there is no record of the antibiotic usage prior
admission to the hospital, as these patients are able to get an anti-
biotic without a medical prescription. Upon admission, after drawl
of the BAL or sputum, patients would be under broad-spectrum
antibiotics (mainly quinolones) as a prophylactic procedure before
the bacteriology laboratory report. Such a situation makes it diffi-
cult to isolate L. pneumophila strains from clinical specimens.
Another important finding is the nosocomial health risk to sus-
ceptible patients, difficulty in relating clinical and environmental
samples always stated [30–32], since ST 1 was the most predomin-
ant ST in both clinical and environmental samples, and even
though we cannot prove a direct link between the ST types from
the clinical samples and the ST of the environmental samples.
Fig. 3. Sequence types (STs) in clinical and environmental
samples. ND = no ST identified. (a) ST distribution in respiratory
tract samples. (b) ST distribution in environmental samples.
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On the other hand, the occurrence of same L. pneumophila STs in
the environmental samples poses a risk, and sustainable monitor-
ing of hospital water systems is recommended [33]. Nowadays,
WGS has been successfully applied for L. pneumophila providing
the highest conceivable discriminatory power to distinguish out-
break from non-outbreak isolates [34, 35]. To this end, further gen-
omic and metagenomics studies are needed using DNA from the
clinical and environmental samples used in this study [36].
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